Literature DB >> 11713229

Orexin A interactions in the hypothalamo-pituitary gonadal axis.

S H Russell1, C J Small, A R Kennedy, S A Stanley, A Seth, K G Murphy, S Taheri, M A Ghatei, S R Bloom.   

Abstract

The distribution of orexin A-immunoreactive neurons and orexin type I receptors in the CNS suggests important roles in regulating the hypothalamo-pituitary gonadal (HPG) axis and sexual behaviors. We examined orexin A interactions in the HPG axis in vivo and in vitro. Orexin A stimulated LH-releasing hormone (LHRH) release in hypothalamic explants harvested from male rats (+133%) and from females at proestrus (+233%), with no effect at estrus or metestrus. Orexin A dose dependently inhibited LHRH-stimulated LH release in dispersed pituitaries from proestrous females only. A selective NPY1-receptor antagonist abolished in vitro release of LHRH by orexin A. Hyperestrogenization in female rats reduced orexin A content in hypothalamus (-28%), midbrain (-26%), medulla (-40%), thalamus (-36%), olfactory tubercles (-25%), and cortex (-35%), brain regions that are important in HPG control and sex-cycle specific behaviors. Orexin A content was lower in hypothalamus (-20%) and higher in midbrain (+40%), medulla (+31%), and thalamus (+33%) at late proestrus vs. other cycle stages. Orexin A release after administration of 56 mM KCl was significantly greater in hypothalamic explants harvested on the morning of proestrus than at estrus or metestrus, and orexin A release was stimulated by estradiol (E2) in explants from males. These results reveal important interactions for orexin A in the HPG axis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713229     DOI: 10.1210/endo.142.12.8558

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems.

Authors:  Jan Kaslin; Johanna M Nystedt; Maria Ostergård; Nina Peitsaro; Pertti Panula
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

Review 2.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 3.  Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?

Authors:  Shaun Yon-Seng Khoo; Robyn Mary Brown
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

Review 4.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

5.  Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons.

Authors:  Ravid Sasson; Robert K Dearth; Rachel S White; Patrick E Chappell; Pamela L Mellon
Journal:  Neuroendocrinology       Date:  2006-12-28       Impact factor: 4.914

Review 6.  Effects of sex and gender on adaptations to space: reproductive health.

Authors:  April E Ronca; Ellen S Baker; Tamara G Bavendam; Kevin D Beck; Virginia M Miller; Joseph S Tash; Marjorie Jenkins
Journal:  J Womens Health (Larchmt)       Date:  2014-11       Impact factor: 2.681

Review 7.  Oestrogen modulates hypothalamic control of energy homeostasis through multiple mechanisms.

Authors:  T A Roepke
Journal:  J Neuroendocrinol       Date:  2008-12-06       Impact factor: 3.627

8.  Hedonic Eating: Sex Differences and Characterization of Orexin Activation and Signaling.

Authors:  Laura Buczek; Jennifer Migliaccio; Gorica D Petrovich
Journal:  Neuroscience       Date:  2020-04-10       Impact factor: 3.590

Review 9.  The role of hypocretin in driving arousal and goal-oriented behaviors.

Authors:  Benjamin Boutrel; Nazzareno Cannella; Luis de Lecea
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

10.  Steady-state methadone effect on generalized arousal in male and female mice.

Authors:  N Devidze; Y Zhou; A Ho; Q Zhang; D W Pfaff; M J Kreek
Journal:  Behav Neurosci       Date:  2008-12       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.